Cargando…

Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Detalles Bibliográficos
Autores principales:	Correll, C. U., Agid, Ofer, Crespo-Facorro, Benedicto, de Bartolomeis, Andrea, Fagiolini, Andrea, Seppälä, Niko, Howes, Oliver D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477893/ https://www.ncbi.nlm.nih.gov/pubmed/35976566 http://dx.doi.org/10.1007/s40263-022-00946-w

Ejemplares similares

A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
por: Correll, C. U., et al.
Publicado: (2022)

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
por: Potkin, Steven G., et al.
Publicado: (2020)

Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review
por: Roiz-Santiañez, Roberto, et al.
Publicado: (2015)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

An evaluation of barriers to the initiation of clozapine in patients with treatment-resistant schizophrenia
por: Hyland, Declan, et al.
Publicado: (2021)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2015)

S202. PROXIMAL AND DISTAL FACTORS ASSOCIATED WITH CLOZAPINE EXPOSURE IN A SAMPLE OF TREATMENT RESISTANT AND TREATMENT RESPONSIVE SCHIZOPHRENIA PATIENTS
por: Barone, Annarita, et al.
Publicado: (2020)

T204. CLOZAPINE COMBINATION AND AUGMENTATION STRATEGIES IN PATIENTS WITH SCHIZOPHRENIA –RECOMMENDATIONS FROM AN INTERNATIONAL EXPERT SURVEY AMONG THE TREATMENT RESPONSE AND RESISTANCE IN PSYCHOSIS (TRRIP) WORKING GROUP
por: Wagner, Elias, et al.
Publicado: (2020)

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
por: de Bartolomeis, Andrea, et al.
Publicado: (2016)

Effectiveness of clozapine in treatment-resistant schizophrenia
por: Raguraman, Janakiraman, et al.
Publicado: (2005)

AN OPEN STUDY OF CLOZAPINE IN THE TREATMENT OF RESISTANT SCHIZOPHRENIA
por: Desai, Neena, et al.
Publicado: (1999)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

An international clozapine titration guideline for clozapine: An opportunity for moving forward on personalizing clozapine treatment in India and other countries
por: de Leon, Jose
Publicado: (2022)

Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and Perceptions
por: Velligan, Dawn I., et al.
Publicado: (2019)

Brief greeting and shared vision()
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Combination of Electroconvulsive Therapy and Clozapine in Treatment-Resistant Schizophrenia
por: Kim, Jung Hyun, et al.
Publicado: (2018)

Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine
por: Tundo, Antonio, et al.
Publicado: (2017)

Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
por: Krajner, Fanni, et al.
Publicado: (2022)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
por: Peitl, Vjekoslav, et al.
Publicado: (2023)

Successful use of adjuvant raloxifene treatment in clozapine-resistant schizophrenia
por: Shivakumar, Venkataram, et al.
Publicado: (2012)

Efficacy and Tolerability of Clozapine versus Quetiapine in Treatment-resistant Schizophrenia
por: Kumar, Mitesh, et al.
Publicado: (2017)

Long-term treatment with clozapine and verbal memory performance in schizophrenia
por: Czepielewski, Letícia S., et al.
Publicado: (2018)

Barriers to using clozapine in treatment-resistant schizophrenia: systematic review
por: Farooq, Saeed, et al.
Publicado: (2019)

Reelin Alterations, Behavioral Phenotypes, and Brain Anomalies in Schizophrenia: A Systematic Review of Insights From Rodent Models
por: Sánchez-Hidalgo, Ana C., et al.
Publicado: (2022)

Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2016)

Cognitive discrepancies, motivation and subjective well-being in people with schizophrenia
por: Krzyzanowski, Daniel, et al.
Publicado: (2021)

Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia
por: Kikuchi, Yuka Sugawara, et al.
Publicado: (2019)

Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study
por: Hatano, Masakazu, et al.
Publicado: (2023)

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery
por: Arango, Celso, et al.
Publicado: (2023)

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery
por: Arango, Celso, et al.
Publicado: (2023)

F121. DOES RELAPSE CONTRIBUTE TO TREATMENT RESISTANCE? ANTIPSYCHOTIC RESPONSE IN FIRST- VS. SECOND-EPISODE SCHIZOPHRENIA
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2018)

Towards a framework for treatment effectiveness in schizophrenia
por: Juckel, Georg, et al.
Publicado: (2014)

USE OF CLOZAPINE IN CHILDHOOD SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1997)

Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals
por: Flanagan, R J, et al.
Publicado: (2020)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpkc4dv375j233bj71dd4606f7